Source: American Banking and Market News

Cynapsus: Cynapsus Therapeutics Inc. (CYNA) Hits New 52-Week High at $40.13

Cynapsus Therapeutics Inc. (NASDAQ:CYNA) shares hit a new 52-week high on Wednesday . The stock traded as high as $40.13 and last traded at $40.13, with a volume of 154,781 shares trading hands. The stock had previously closed at $40.00. Several brokerages have recently weighed in on CYNA. Janney Montgomery Scott downgraded shares of Cynapsus [...]

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Anthony J. Giovinazzo's photo - President & CEO of Cynapsus

President & CEO

Anthony J. Giovinazzo

CEO Approval Rating

68/100

Read more